Prostate Cancer: 7 Early Symptoms, Tests, And Diagnosis
A personal journey through the early detection and diagnosis of prostate cancer, highlighting symptoms, tests, and emotional challenges.
Road to Diagnosis: Prostate Cancer
Prostate cancer remains one of the most common cancers affecting men, with early detection playing a crucial role in successful outcomes. This article follows Mark’s personal journey—a 58-year-old father and husband—as he navigates vague symptoms, screening tests, and the path to a definitive diagnosis. His story underscores the importance of awareness, proactive health checks, and understanding the diagnostic process.
What Are the Symptoms of Prostate Cancer?
Prostate cancer often develops silently in its early stages, earning it a reputation as a “silent killer.” Many men experience no symptoms until the disease advances. When symptoms do appear, they can mimic less serious conditions like benign prostatic hyperplasia (BPH) or urinary tract infections, leading to delays in seeking care.
Mark first noticed something amiss during a routine evening routine. “I started getting up multiple times at night to urinate—maybe four or five times,” he recalls. “During the day, the stream was weaker, and it took longer to empty my bladder.” These lower urinary tract symptoms (LUTS) are classic red flags.
- Frequent urination, especially at night (nocturia)
- Weak or interrupted urine flow
- Difficulty starting urination
- Blood in urine (hematuria) or semen
- Pain or burning during urination
- Erectile dysfunction or painful ejaculation
- Bone pain or unexplained weight loss (advanced stages)
According to the National Cancer Institute (NCI), about 1 in 8 men will be diagnosed with prostate cancer in their lifetime, but symptoms alone cannot confirm the disease. Mark’s primary care physician emphasized this: “These signs overlap with many benign issues, so testing is essential.”
The First Step: Digital Rectal Exam (DRE)
Concerned by Mark’s symptoms, his doctor recommended starting with a digital rectal exam (DRE). This quick, in-office procedure involves the physician inserting a gloved, lubricated finger into the rectum to feel the prostate gland for abnormalities.
“It was awkward but not painful,” Mark says. “The doctor felt a nodule on one side—hard and irregular. That’s when things got real.”
A normal prostate feels smooth and symmetrical, like the tip of the nose. Abnormal findings include:
- Nodules or lumps
- Asymmetry or enlargement
- Hard, irregular texture
While DRE detects about 20% of prostate cancers, it’s often combined with other tests for accuracy. Mark’s abnormal DRE prompted the next critical step.
PSA Test: The Blood Test That Changed Everything
The prostate-specific antigen (PSA) test measures levels of a protein produced by prostate cells in the blood. Elevated PSA can signal cancer, inflammation, BPH, or infection—but it’s not definitive.
| PSA Level (ng/mL) | Risk Interpretation |
|---|---|
| <4 | Normal range (age-adjusted) |
| 4–10 | Borderline; 25% chance of cancer |
| >10 | High; 50%+ chance of cancer |
Mark’s PSA came back at 7.2 ng/mL—elevated for his age. “I went home and Googled it,” he admits. “The stats were scary, but my urologist explained it’s just a piece of the puzzle.”
Refinements like free PSA ratio, PSA density, and velocity help interpret results. The American Urological Association (AUA) recommends shared decision-making for PSA screening in men 55–69.
Imaging Tests: MRI and Beyond
With elevated PSA and abnormal DRE, Mark underwent a multiparametric MRI (mpMRI). This advanced scan uses magnetic fields to produce detailed prostate images, identifying suspicious lesions.
- T2-weighted imaging: Shows anatomy
- Diffusion-weighted imaging (DWI): Detects cell density
- Dynamic contrast enhancement: Measures blood flow
Results use the PI-RADS score (1–5), with 4–5 indicating high cancer likelihood. Mark’s PI-RADS 4 lesion targeted the biopsy precisely. “The MRI gave us a roadmap,” his urologist noted.
Other imaging includes transrectal ultrasound (TRUS) for biopsy guidance and bone scans for metastasis staging.
The Biopsy: Confirming the Diagnosis
Fear gripped Mark before the transrectal ultrasound-guided (TRUS) biopsy. Under local anesthesia, needles extract 12–14 tissue cores from the prostate.
Biopsy Facts
- Outpatient procedure (15–30 minutes)
- Antibiotics prevent infection
- Side effects: blood in urine/semen, temporary urinary issues
- Results in 1–2 weeks
“The anticipation was worse than the procedure,” Mark shares. Pathology revealed cancer in 4 of 12 cores.
Understanding Gleason Score and Grade Groups
The Gleason score grades cancer aggressiveness by microscopic patterns (1–5). Primary + secondary patterns yield scores like 3+4=7.
| Gleason Score | Grade Group | Risk Level |
|---|---|---|
| ≤6 | 1 | Low |
| 3+4=7 | 2 | Favorable intermediate |
| 4+3=7 | 3 | Unfavorable intermediate |
| 8 | 4 | High |
| 9–10 | 5 | Very high |
Mark’s Gleason 3+4=7 (Grade Group 2) indicated intermediate-risk cancer. “Numbers became my life,” he says. The World Health Organization endorses this system for prognosis.
Staging the Cancer
Staging uses TNM system:
- T (Tumor): Size/extent (T1–T4)
- N (Nodes): Lymph node spread
- M (Metastasis): Distant spread
Mark’s T2c N0 M0 meant organ-confined disease. PSA density and percentage of positive cores further informed risk.
Emotional Roadblocks and Support
Beyond tests, diagnosis brings fear, anxiety, and relationship strains. Mark leaned on:
- Spouse and family
- Urology nurse navigators
- Support groups like Prostate Cancer Foundation
- Counseling
“Talk about it,” he advises. “Bottling emotions delays decisions.”
Treatment Decisions After Diagnosis
Options vary by stage:
| Approach | Best For |
|---|---|
| Active Surveillance | Low-risk |
| Surgery (Prostatectomy) | Localized |
| Radiation Therapy | Localized/advanced |
| Hormone Therapy | Advanced |
Mark chose robotic prostatectomy. Multidisciplinary clinics aided his choice.
Frequently Asked Questions (FAQs)
What is the PSA test and when should men get screened?
The PSA blood test detects prostate-specific antigen levels. The USPSTF recommends shared decision-making for men 55–69; earlier for high-risk groups (African American, family history).
Is an abnormal DRE always cancer?
No—DRE detects lumps but cannot distinguish cancer from BPH or infection. Biopsy confirms diagnosis.
What does Gleason 7 mean?
Gleason 3+4=7 is intermediate-risk; pattern 4 percentage matters (10–50% is favorable). Grade Group 2.
Can prostate cancer be cured if caught early?
Yes—5-year survival for localized cancer exceeds 99% per NCI data. Early detection saves lives.
How has MRI changed prostate cancer diagnosis?
mpMRI reduces unnecessary biopsies by 30% and targets suspicious areas, improving accuracy per recent studies.
References
- Prostate Cancer Early Detection Guideline — American Urological Association. 2023. https://www.auanet.org/guidelines-and-quality/guidelines/prostate-cancer-early-detection-guideline
- Prostate Cancer Statistics — National Cancer Institute. 2024-01-12. https://www.cancer.gov/types/prostate
- Prostate Cancer Screening — U.S. Preventive Services Task Force. 2023-11. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening
- PI-RADS Prostate Imaging-Reporting and Data System — American College of Radiology. 2024. https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/PI-RADS
- Prostate Cancer Treatment (PDQ®)–Health Professional Version — National Cancer Institute. 2025-01-10. https://www.cancer.gov/types/prostate/hp/prostate-treatment-pdq
- Contemporary Grading of Prostate Cancer — Epstein JI et al. European Urology. 2021-06-15. https://doi.org/10.1016/j.eururo.2020.11.045
Similar Articles
Read full bio of Sneha Tete
